{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T10:47:51Z","timestamp":1792234071761,"version":"4.4.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2013,9,5]],"date-time":"2013-09-05T00:00:00Z","timestamp":1378339200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1007\/s00213-013-3263-x","type":"journal-article","created":{"date-parts":[[2013,9,4]],"date-time":"2013-09-04T12:05:30Z","timestamp":1378296330000},"page":"999-1009","source":"Crossref","is-referenced-by-count":76,"title":["Psychopharmacological prescriptions for people with autism spectrum disorder (ASD): a multinational study"],"prefix":"10.1007","volume":"231","author":[{"given":"Yingfen","family":"Hsia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angel Y. S.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Declan G. M.","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Simonoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan K.","family":"Buitelaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian C. K.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,9,5]]},"reference":[{"issue":"5","key":"3263_CR1","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1136\/archdischild-2011-300054","volume":"96","author":"NB Almandil","year":"2011","unstructured":"Almandil NB, Wong IC (2011) Review on the current use of antipsychotic drugs in children and adolescents. Arch Dis Child Educ Pract Ed 96(5):192\u2013196","journal-title":"Arch Dis Child Educ Pract Ed"},{"issue":"2","key":"3263_CR2","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s40272-013-0016-6","volume":"15","author":"NB Almandil","year":"2013","unstructured":"Almandil NB, Liu Y, Murray ML, Besag FM, Aitchison KJ, Wong IC (2013) Weight gain and other metabolic adverse effects associated with atypical antipsychotic treatment of children and adolescents: a systematic review and meta-analysis. Paediatr Drugs 15(2):139\u2013150","journal-title":"Paediatr Drugs"},{"key":"3263_CR3","unstructured":"Autism Speaks (2009) Autism Speaks announces results reported for the Study of Fluoxetine in Autism (SOFIA). http:\/\/www.autismspeaks.org\/about-us\/press-releases\/autism-speaks-announces-results-reported-study-fluoxetine-autism-sofia . Accessed 13 May 2013"},{"issue":"9531","key":"3263_CR4","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S0140-6736(06)69041-7","volume":"368","author":"G Baird","year":"2006","unstructured":"Baird G, Simonoff E, Pickles A, Chandler S, Loucas T, Meldrum D, Charman T (2006) Prevalence of disorders of the autism spectrum in a population cohort of children in South Thames: the Special Needs and Autism Project (SNAP). Lancet 368(9531):210\u2013215","journal-title":"Lancet"},{"issue":"6","key":"3263_CR5","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/jhh.2008.139","volume":"23","author":"R Balkrishnan","year":"2009","unstructured":"Balkrishnan R, Phatak H, Gleim G, Karve S (2009) Assessment of the use of angiotensin receptor blockers in major European markets among paediatric population for treating essential hypertension. J Hum Hypertens 23(6):420\u2013425","journal-title":"J Hum Hypertens"},{"key":"3263_CR6","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1192\/bjp.bp.105.018127","volume":"189","author":"E Bradley","year":"2006","unstructured":"Bradley E, Bolton P (2006) Episodic psychiatric disorders in teenagers with learning disabilities with and without autism. Br J Psychiatry 189:361\u2013366","journal-title":"Br J Psychiatry"},{"issue":"9","key":"3263_CR7","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.jaac.2012.06.017","volume":"51","author":"T Cadman","year":"2012","unstructured":"Cadman T, Eklund H, Howley D, Hayward H, Clarke H, Findon J, Xenitidis K, Murphy D, Asherson P, Glaser K (2012) Caregiver burden as people with autism spectrum disorder and attention-deficit\/hyperactivity disorder transition into adolescence and adulthood in the United Kingdom. J Am Acad Child Adolesc Psychiatry 51(9):879\u2013888","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"4","key":"3263_CR8","first-page":"453","volume":"81","author":"PS Carbone","year":"2010","unstructured":"Carbone PS, Farley M, Davis T (2010) Primary care for children with autism. Am Fam Physician 81(4):453\u2013460","journal-title":"Am Fam Physician"},{"issue":"Suppl 2","key":"3263_CR9","doi-asserted-by":"crossref","first-page":"S69","DOI":"10.1542\/peds.2012-0900D","volume":"130","author":"DL Coury","year":"2012","unstructured":"Coury DL, Anagnostou E, Manning-Courtney P, Reynolds A, Cole L, McCoy R, Whitaker A, Perrin JM (2012) Use of psychotropic medication in children and adolescents with autism spectrum disorders. Pediatrics 130(Suppl 2):S69\u2013S76","journal-title":"Pediatrics"},{"issue":"1","key":"3263_CR10","first-page":"8","volume":"25","author":"JM Farrugia","year":"2013","unstructured":"Farrugia JM (2013) The use or misuse of biomedical treatment approaches to autism. Malta Med J 25(1):8\u201314","journal-title":"Malta Med J"},{"issue":"1","key":"3263_CR11","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1001\/jama.289.1.87","volume":"289","author":"E Fombonne","year":"2003","unstructured":"Fombonne E (2003) The prevalence of autism. JAMA 289(1):87\u201389","journal-title":"JAMA"},{"issue":"6","key":"3263_CR12","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1089\/cap.2011.0057","volume":"21","author":"TW Frazier","year":"2011","unstructured":"Frazier TW, Shattuck PT, Narendorf SC, Cooper BP, Wagner M, Spitznagel EL (2011) Prevalence and correlates of psychotropic medication use in adolescents with an autism spectrum disorder with and without caregiver-reported attention-deficit\/hyperactivity disorder. J Child Adolesc Psychopharmacol 21(6):571\u2013579","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"3263_CR13","doi-asserted-by":"crossref","first-page":"e6664","DOI":"10.1136\/bmj.e6664","volume":"345","author":"P Gringras","year":"2012","unstructured":"Gringras P, Gamble C, Jones AP, Wiggs L, Williamson PR, Sutcliffe A, Montgomery P, Whitehouse WP, Choonara I, Allport T, Edmond A, Appleton R, MENDS Study Group (2012) Melatonin for sleep problems in children with neurodevelopmental disorders: randomised double masked placebo controlled trial. BMJ 345:e6664","journal-title":"BMJ"},{"issue":"9385","key":"3263_CR14","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/S0140-6736(03)14236-5","volume":"362","author":"E Hollander","year":"2003","unstructured":"Hollander E, Phillips AT, Yeh CC (2003) Targeted treatments for symptom domains in child and adolescent autism. Lancet 362(9385):732\u2013734","journal-title":"Lancet"},{"issue":"2","key":"3263_CR15","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1017\/S1461145705005791","volume":"9","author":"E Hollander","year":"2006","unstructured":"Hollander E, Soorya L, Wasserman S, Esposito K, Chaplin W, Anagnostou E (2006) Divalproex sodium vs. placebo in the treatment of repetitive behaviours in autism spectrum disorder. Int J Neuropsychopharmacol 9(2):209\u2013213","journal-title":"Int J Neuropsychopharmacol"},{"issue":"4","key":"3263_CR16","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1038\/npp.2009.202","volume":"35","author":"E Hollander","year":"2010","unstructured":"Hollander E, Chaplin W, Soorya L, Wasserman S, Novotny S, Rusoff J, Feirsen N, Pepa L, Anagnostou E (2010) Divalproex sodium vs placebo for the treatment of irritability in children and adolescents with autism spectrum disorders. Neuropsychopharmacology 35(4):990\u2013998","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"3263_CR17","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1176\/appi.ajp.2011.10050764","volume":"169","author":"E Hollander","year":"2012","unstructured":"Hollander E, Soorya L, Chaplin W, Anagnostou E, Taylor BP, Ferretti CJ, Wasserman S, Swanson E, Settipani C (2012) A double-blind placebo-controlled trial of fluoxetine for repetitive behaviors and global severity in adult autism spectrum disorders. Am J Psychiatry 169(3):292\u2013299","journal-title":"Am J Psychiatry"},{"issue":"6","key":"3263_CR18","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1001\/archgenpsychiatry.2009.30","volume":"66","author":"BH King","year":"2009","unstructured":"King BH, Hollander E, Sikich L et al (2009) Lack of efficacy of citalopram in children with autism spectrum disorders and high levels of repetitive behavior: citalopram ineffective in children with autism. Arch Gen Psychiatry 66(6):583\u2013590","journal-title":"Arch Gen Psychiatry"},{"issue":"4","key":"3263_CR19","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.ijantimicag.2006.05.025","volume":"28","author":"DM Livermore","year":"2006","unstructured":"Livermore DM, Reynolds R, Stephens P, Duckworth G, Felmingham D, Johnson AP, Murchan S, Murphy O, Gungabissoon U, Waight P, Pebody R, Shackcloth J, Warner M, Williams L, George RC (2006) Trends in penicillin and macrolide resistance among pneumococci in the UK and the Republic of Ireland in relation to antibiotic sales to pharmacies and dispensing doctors. Int J Antimicrob Agents 28(4):273\u2013279","journal-title":"Int J Antimicrob Agents"},{"key":"3263_CR20","first-page":"870391","volume":"2012","author":"N Lofthouse","year":"2012","unstructured":"Lofthouse N, Hendren R, Hurt E, Arnold LE, Butter E (2012) A review of complementary and alternative treatments for autism spectrum disorders. Autism Res Treat 2012:870391. doi: 10.1155\/2012\/870391","journal-title":"Autism Res Treat"},{"issue":"1","key":"3263_CR21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.annepidem.2011.10.007","volume":"22","author":"SL Logan","year":"2012","unstructured":"Logan SL, Nicholas JS, Carpenter LA, King LB, Garrett-Mayer E, Charles JM (2012) High prescription drug use and associated costs among Medicaid-eligible children with autism spectrum disorders identified by a population-based surveillance network. Ann Epidemiol 22(1):1\u20138","journal-title":"Ann Epidemiol"},{"key":"3263_CR22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.rasd.2008.06.001","volume":"3","author":"B MacNeil","year":"2009","unstructured":"MacNeil B, Lopes V, Minnes P (2009) Anxiety in children and adolescents with autism spectrum disorders. Res Autism Spectrum Disord 3:1\u201321","journal-title":"Res Autism Spectrum Disord"},{"issue":"3","key":"3263_CR23","doi-asserted-by":"crossref","first-page":"e441","DOI":"10.1542\/peds.2007-0984","volume":"121","author":"DS Mandell","year":"2008","unstructured":"Mandell DS, Morales KH, Marcus SC, Stahmer AC, Doshi J, Polsky DE (2008) Psychotropic medication use among Medicaid-enrolled children with autism spectrum disorders. Pediatrics 121(3):e441\u2013e448","journal-title":"Pediatrics"},{"issue":"11","key":"3263_CR24","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1097\/CHI.0b013e3181b76658","volume":"48","author":"RN Marcus","year":"2009","unstructured":"Marcus RN, Owen R, Kamen L, Manos G, McQuade RD, Carson WH, Aman MG (2009) A placebo-controlled, fixed-dose study of aripiprazole in children and adolescents with irritability associated with autistic disorder. J Am Acad Child Adolesc Psychiatry 48(11):1110\u20131119","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"3263_CR25","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.rasd.2009.06.003","volume":"3","author":"JL Matson","year":"2009","unstructured":"Matson JL, Neal D (2009) Seizures and epilepsy and their relationship to autism spectrum disorders. Res Autism Spectrum Disorder 3:999\u20131005","journal-title":"Res Autism Spectrum Disorder"},{"issue":"3","key":"3263_CR26","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1192\/bjp.bp.107.045245","volume":"194","author":"S McCarthy","year":"2009","unstructured":"McCarthy S, Asherson P, Coghill D, Hollis C, Murray M, Potts L, Sayal K, de Soysa R, Taylor E, Williams T, Wong IC (2009) Attention-deficit hyperactivity disorder: treatment discontinuation in adolescents and young adults. Br J Psychiatry 194(3):273\u2013277","journal-title":"Br J Psychiatry"},{"key":"3263_CR27","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1186\/1471-244X-12-219","volume":"12","author":"S McCarthy","year":"2012","unstructured":"McCarthy S, Wilton L, Murray ML, Hodgkins P, Asherson P, Wong IC (2012) Persistence of pharmacological treatment into adulthood, in UK primary care, for ADHD patients who started treatment in childhood or adolescence. BMC Psychiatry 12:219. doi: 10.1186\/1471-244X-12-219","journal-title":"BMC Psychiatry"},{"issue":"5","key":"3263_CR28","doi-asserted-by":"crossref","first-page":"e1312","DOI":"10.1542\/peds.2011-0427","volume":"127","author":"ML McPheeters","year":"2011","unstructured":"McPheeters ML, Warren Z, Sathe N, Bruzek JL, Krishnaswami S, Jerome RN, Veenstra-Vanderweele J (2011) A systematic review of medical treatments for children with autism spectrum disorders. Pediatrics 127(5):e1312\u2013e1321","journal-title":"Pediatrics"},{"issue":"7","key":"3263_CR29","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.braindev.2007.12.007","volume":"30","author":"X Ming","year":"2008","unstructured":"Ming X, Gordon E, Kang N, Wagner GC (2008) Use of clonidine in children with autism spectrum disorders. Brain Dev 30(7):454\u2013460","journal-title":"Brain Dev"},{"key":"3263_CR30","doi-asserted-by":"crossref","unstructured":"Murray ML, Hsia Y, Glaser K, Simonoff E, Murphy D, Asherson PJ, Eklund H, Wong ICK (2013) Pharmacological treatment prescribed to people with autism spectrum disorder (ASD) in primary health care. Psychopharmacology (Berl). doi: 10.1007\/s00213-013-3140-7","DOI":"10.1007\/s00213-013-3140-7"},{"issue":"5","key":"3263_CR31","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1542\/peds.2007-2362","volume":"120","author":"SM Myers","year":"2007","unstructured":"Myers SM, Johnson CP, American Academy of Pediatrics Council on Children with Disabilities (2007) Management of children with autism spectrum disorders. Pediatrics 120(5):1162\u20131182","journal-title":"Pediatrics"},{"issue":"6","key":"3263_CR32","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1542\/peds.2008-3782","volume":"124","author":"R Owen","year":"2009","unstructured":"Owen R, Sikich L, Marcus RN, Corey-isle P, Manos G, McQuade RD, Carson WH, Findling RL (2009) Aripiprazole in the treatment of irritability in children and adolescents with autistic disorder. Pediatrics 124(6):1533\u20131540","journal-title":"Pediatrics"},{"issue":"1","key":"3263_CR33","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/01.mlr.0000189036.11725.a6","volume":"44","author":"NC Patel","year":"2006","unstructured":"Patel NC, Crismon ML, Hoagwood K, Johnsrud MT, Rascati KL, Wilson JP (2006) Physician specialty associated with antipsychotic prescribing for youths in the Texas Medicaid program. Med Care 44(1):87\u201390","journal-title":"Med Care"},{"key":"3263_CR34","doi-asserted-by":"crossref","unstructured":"Politte LC, McDougle CJ (2013) Atypical antipsychotics in the treatment of children and adolescents with pervasive developmental disorders. Psychopharmacology (Berl). doi: 10.1007\/s00213-013-3068-y","DOI":"10.1007\/s00213-013-3068-y"},{"issue":"1","key":"3263_CR35","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1172\/JCI32483","volume":"118","author":"DJ Posey","year":"2008","unstructured":"Posey DJ, Stigler KA, Erickson CA, McDougle CJ (2008) Antipsychotics in the treatment of autism. J Clin Invest 118(1):6\u201314","journal-title":"J Clin Invest"},{"issue":"5","key":"3263_CR36","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1542\/peds.2007-2008","volume":"121","author":"F Rani","year":"2008","unstructured":"Rani F, Murray ML, Byrne PJ, Wong IC (2008) Epidemiologic features of antipsychotic prescribing to children and adolescents in primary care in the United Kingdom. Pediatrics 121(5):1002\u20131009","journal-title":"Pediatrics"},{"issue":"4","key":"3263_CR37","doi-asserted-by":"crossref","first-page":"325","DOI":"10.2165\/00002018-200932040-00006","volume":"32","author":"FA Rani","year":"2009","unstructured":"Rani FA, Byrne PJ, Murray ML, Carter P, Wong IC (2009) Paediatric atypical antipsychotic monitoring safety (PAMS) study: pilot study in children and adolescents in secondary- and tertiary-care settings. Drug Saf 32(4):325\u2013333","journal-title":"Drug Saf"},{"issue":"9","key":"3263_CR38","doi-asserted-by":"crossref","first-page":"773","DOI":"10.2165\/11591120-000000000-00000","volume":"34","author":"FA Rani","year":"2011","unstructured":"Rani FA, Byrne P, Cranswick N, Murray ML, Wong IC (2011) Mortality in children and adolescents prescribed antipsychotic medication: a retrospective cohort study using the UK general practice research database. Drug Saf 34(9):773\u2013781","journal-title":"Drug Saf"},{"issue":"4","key":"3263_CR39","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1089\/cap.2008.0120","volume":"19","author":"Y Roke","year":"2009","unstructured":"Roke Y, van Harten PN, Boot AM, Buitelaar JK (2009) Antipsychotic medication in children and adolescents: a descriptive review of the effects on prolactin level and associated side effects. J Child Adolesc Psychopharmacol 19(4):403\u2013414","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"6","key":"3263_CR40","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1089\/cap.2011.0109","volume":"22","author":"Y Roke","year":"2012","unstructured":"Roke Y, Buitelaar JK, Boot AM, Tenback D, van Harten PN (2012a) Risk of hyperprolactinemia and sexual side effects in males 10\u201320 years old diagnosed with autism spectrum disorders or disruptive behavior disorder and treated with risperidone. J Child Adolesc Psychopharmacol 22(6):432\u2013439","journal-title":"J Child Adolesc Psychopharmacol"},{"issue":"6","key":"3263_CR41","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1530\/EJE-12-0521","volume":"167","author":"Y Roke","year":"2012","unstructured":"Roke Y, van Harten PN, Buitelaar JK, Tenback DE, Quekel LG, de Rijke YB, Boot AM (2012b) Bone mineral density in male adolescents with autism spectrum disorders and disruptive behavior disorder with or without antipsychotic treatment. Eur J Endocrinol 167(6):855\u2013863","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"3263_CR42","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1159\/000337910","volume":"77","author":"Y Roke","year":"2012","unstructured":"Roke Y, van Harten PN, Buitelaar JK, Tenback DE, de Rijke YB, Boot AM (2012c) Antipsychotic-induced hyperprolactinemia and testosterone levels in boys. Horm Res Paediatr 77(4):235\u2013240","journal-title":"Horm Res Paediatr"},{"issue":"3","key":"3263_CR43","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1007\/s10803-009-0878-1","volume":"40","author":"RE Rosenberg","year":"2010","unstructured":"Rosenberg RE, Mandell DS, Farmer JE, Law JK, Marvin AR, Law PA (2010) Psychotropic medication use among children with autism spectrum disorders enrolled in a national registry, 2007\u20132008. J Autism Dev Disord 40(3):342\u2013351","journal-title":"J Autism Dev Disord"},{"issue":"9","key":"3263_CR44","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/j.1469-8749.2011.03980.x","volume":"53","author":"DA Rossignol","year":"2011","unstructured":"Rossignol DA, Frye RE (2011) Melatonin in autism spectrum disorders: a systematic review and meta-analysis. Dev Med Child Neurol 53(9):783\u2013792","journal-title":"Dev Med Child Neurol"},{"issue":"5","key":"3263_CR45","doi-asserted-by":"crossref","first-page":"e634","DOI":"10.1542\/peds.2003-0264-F","volume":"114","author":"S Shea","year":"2004","unstructured":"Shea S, Turgay A, Carroll A, Schulz M, Orlik H, Smith I, Dunbar F (2004) Risperidone in the treatment of disruptive behavioral symptoms in children with autistic and other pervasive developmental disorders. Pediatrics 114(5):e634\u2013e641","journal-title":"Pediatrics"},{"issue":"8","key":"3263_CR46","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1097\/CHI.0b013e318179964f","volume":"47","author":"E Simonoff","year":"2008","unstructured":"Simonoff E, Pickles A, Charman T, Chandler S, Loucas T, Baird G (2008) Psychiatric disorders in children with autism spectrum disorders: prevalence, comorbidity, and associated factors in a population-derived sample. J Am Acad Child Adolesc Psychiatry 47(8):921\u2013929","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"3263_CR47","doi-asserted-by":"crossref","unstructured":"Souders MC, Mason TB, Valladares O, Bucan M, Levy SE, Mandell DS, Weaver TE, Pinto-Martin J (2009) Sleep behaviors and sleep quality in children with autism spectrum disorders. 32(12):1566\u20131578","DOI":"10.1093\/sleep\/32.12.1566"},{"issue":"6","key":"3263_CR48","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1089\/cap.2011.0134","volume":"22","author":"K Star","year":"2012","unstructured":"Star K, Iessa N, Almandil NB, Wilton L, Curran S, Edwards IR, Wong IC (2012) Rhabdomyolysis reported for children and adolescents treated with antipsychotic medicines: a case series analysis. J Child Adolesc Psychopharmacol 22(6):440\u2013451","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"3263_CR49","unstructured":"The European Medicines Agency (EMA) (2007) Assessment of the paediatric needs psychiatry. Available at: http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Other\/2009\/10\/WC500004046.pdf . Accessed 03 Aug 2013"},{"key":"3263_CR50","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1177\/1362361398021005","volume":"2","author":"FR Volkmar","year":"1998","unstructured":"Volkmar FR (1998) Categorical approaches to the diagnosis of autism: an overview of DSM-IV and ICD-10. Autism 2:45\u201359","journal-title":"Autism"},{"issue":"3","key":"3263_CR51","doi-asserted-by":"crossref","first-page":"229","DOI":"10.31887\/DCNS.2012.14.3\/fvolkmar","volume":"14","author":"FR Volkmar","year":"2012","unstructured":"Volkmar FR, Reichow B, McPartland J (2012) Classification of autism and related conditions: progress, challenges, and opportunities. Dialogues Clin Neurosci 14(3):229\u2013237","journal-title":"Dialogues Clin Neurosci"},{"key":"3263_CR52","doi-asserted-by":"crossref","unstructured":"Williams K, Wheeler DM, Silove N, Hazell P (2010) Selective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders (ASD). Cochrane Database Syst Rev 8:CD004677. doi: 10.1002\/14651858.CD004677","DOI":"10.1002\/14651858.CD004677"},{"issue":"10","key":"3263_CR53","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1177\/0009922812440837","volume":"51","author":"PG Williams","year":"2012","unstructured":"Williams PG, Woods C, Stevenson M, Davis DW, Radmacher P, Smith M (2012) Psychotropic medication use in children with autism in the Kentucky Medicaid population. Clin Pediatr (Phila) 51(10):923\u2013927","journal-title":"Clin Pediatr (Phila)"},{"issue":"6","key":"3263_CR54","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1111\/j.1365-2125.2005.02450.x","volume":"59","author":"IC Wong","year":"2005","unstructured":"Wong IC, Murray ML (2005) The potential of UK clinical databases in enhancing paediatric medication research. Br J Clin Pharmacol 59(6):750\u2013755","journal-title":"Br J Clin Pharmacol"},{"issue":"12","key":"3263_CR55","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1136\/adc.2004.050468","volume":"89","author":"IC Wong","year":"2004","unstructured":"Wong IC, Murray ML, Camilleri-Novak D, Stephens P (2004) Increased prescribing trends of pediatric psychotropic medications. Arch Dis Child 89(12):1131\u20131132","journal-title":"Arch Dis Child"},{"key":"3263_CR56","unstructured":"Wong IC, Asherson P, Bilbow A, Clifford S, Coghill D, DeSoysa R, Hollis C, McCarthy S, Murray M, Planner C, Potts L, Sayal K, Taylor E (2009) Cessation of attention deficit hyperactivity disorder drugs in the young (CADDY)\u2014a pharmacoepidemiological and qualitative study. Health Technol Assess 13(50):1\u2013120 (iii\u2013iv, ix\u2013xi)"},{"key":"3263_CR57","unstructured":"World Health Organisation (2013) Application for inclusion to the 19th expert committee on the selection and use of essential medicines: risperidone. Available at: http:\/\/www.who.int\/selection_medicines\/committees\/expert\/19\/applications\/Risperidone_24_A_Ad_Final.pdf . Accessed 03 Aug 2013"},{"issue":"1","key":"3263_CR58","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1753-2000-2-26","volume":"2","author":"JM Zito","year":"2008","unstructured":"Zito JM, Safer DJ, de Jong-van den Berg LT, Janhsen K, Fegert JM, Gardner JF, Glaeske G, Valluri SC (2008) A three-country comparison of psychotropic medication prevalence in youth. Child Adolesc Psychiatry Ment Health 2(1):26. doi: 10.1186\/1753-2000-2-26","journal-title":"Child Adolesc Psychiatry Ment Health"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-013-3263-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00213-013-3263-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-013-3263-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,4]],"date-time":"2023-07-04T09:13:47Z","timestamp":1688462027000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00213-013-3263-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9,5]]},"references-count":58,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["3263"],"URL":"https:\/\/doi.org\/10.1007\/s00213-013-3263-x","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,9,5]]}}}